Clinical Efficacy of the Huo Xue Hua Yu Method Combined with Aspirin in the Treatment of Acute Cerebral Infarction: A Systematic Evaluation and Meta-analysis.


Journal

Current pharmaceutical design
ISSN: 1873-4286
Titre abrégé: Curr Pharm Des
Pays: United Arab Emirates
ID NLM: 9602487

Informations de publication

Date de publication:
2023
Historique:
received: 21 12 2022
accepted: 18 05 2023
medline: 4 10 2023
pubmed: 23 6 2023
entrez: 23 6 2023
Statut: ppublish

Résumé

The study aimed to evaluate the clinical efficacy of the Huo Xue Hua Yu method combined with aspirin in the treatment of patients with acute cerebral infarction (ACI). By searching electronic databases, such as the Chinese Biomedical Literature Database (CBM), the China National Knowledge Infrastructure Database (CNKI), the China Science and Technology Journal Database, Wanfang, PubMed, Embase, and the Cochrane Library, all randomized controlled trials (RCTs) published before 14 July, 2022, and published in Chinese or English languages were selected. Statistical analysis was performed using Review Manager 5.4 calculation software to calculate the odds ratio (OR), mean difference (MD), 95% confidence interval (CI), and p values. 13 articles that included 1,243 patients were identified; in 646 of them, the Huo Xue Hua Yu method combined with aspirin has been administered, while 597 have only been administered aspirin therapy. The combined treatment significantly improved clinical efficacy (OR: 4.41, 95% CI: 2.90 to 5.84, The combination of the Huo Xue Hua Yu method and aspirin represents a beneficial adjunctive therapy for ACI.

Identifiants

pubmed: 37349997
pii: CPD-EPUB-132612
doi: 10.2174/1381612829666230622110753
doi:

Substances chimiques

Drugs, Chinese Herbal 0
Aspirin R16CO5Y76E

Types de publication

Meta-Analysis Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2009-2017

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Chu Chen (C)

Honghui Hospital, Xi'an JiaoTong University College of Medicine, Xi'an, Shaanxi, 710054, China.
Shaanxi Provincial Hospital of Traditional Chinese Medicine, Xi'an, Shaanxi, 710003, China.

Fang Ma (F)

Shaanxi University of Chinese Medicine, Xian Yang, Shaanxi, 712046, China.

Xinli Wen (X)

Shaanxi Provincial Hospital of Traditional Chinese Medicine, Xi'an, Shaanxi, 710003, China.

Xing Liu (X)

Shaanxi University of Chinese Medicine, Xian Yang, Shaanxi, 712046, China.

Qing Tang (Q)

Clinical Laboratory of Xi'an Daxing Hospital, Xi'an, Shaanxi, 710000, China.

Yilun Wu (Y)

Honghui Hospital, Xi'an JiaoTong University College of Medicine, Xi'an, Shaanxi, 710054, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH